1. Academic Validation
  2. Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy

Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy

  • Signal Transduct Target Ther. 2023 Dec 15;8(1):454. doi: 10.1038/s41392-023-01715-x.
Lei Yu # 1 Pengcheng Zhao # 1 Yaoliang Sun # 2 Zening Zheng # 1 Wenhao Du 2 Lishan Zhang 2 Yaxu Li 1 Longyan Xie 1 Shilin Xu 3 Ping Wang 4
Affiliations

Affiliations

  • 1 Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • 2 Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • 3 Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. slxu@simm.ac.cn.
  • 4 Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. wangp@tongji.edu.cn.
  • # Contributed equally.
Figures
Products